AN2 Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
RA CAPITAL MANAGEMENT, L.P. 10 percent owner
 Common Stock 1,809 $7.48 $13,531
Purchase
RA CAPITAL MANAGEMENT, L.P. 10 percent owner
 Common Stock 8,281 $7.91 $65,503
Purchase
RA CAPITAL MANAGEMENT, L.P. 10 percent owner
 Common Stock 14,938 $7.71 $115,172
Purchase
RA CAPITAL MANAGEMENT, L.P. 10 percent owner
 Common Stock 302 $7.99 $2,413
Purchase
RA CAPITAL MANAGEMENT, L.P. 10 percent owner
 Common Stock 61,424 $7.97 $489,426
Purchase
RA CAPITAL MANAGEMENT, L.P. 10 percent owner
 Common Stock 20,000 $7.9 $158,000
Purchase
AZIZ KABEER director, 10 percent owner
 Common Stock 166,666 $15 $2,499,990
Purchase
ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P. 10 percent owner
 Common Stock 166,666 $15 $2,499,990
Purchase
READNOUR ROBIN SHANE director
 Common Stock 82,618 $15 $1,239,270
Purchase
READNOUR ROBIN SHANE director
 Common Stock 70,716 $15 $1,060,740
Purchase
RA CAPITAL MANAGEMENT, L.P. 10 percent owner
 Common Stock 115,613 $15 $1,734,195
Purchase
RA CAPITAL MANAGEMENT, L.P. 10 percent owner
 Common Stock 1,551,053 $15 $23,265,795

Showing 100 to 112 of 112 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: